porno izle
women desperate to piss ava addams mom porn sa akin ang gabi
sisli escort mecidiyekoy escort
replica watches
Neodyum Miknatis

Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

From the monthly archives: February 2020

We are pleased to present below all posts archived in 'February 2020'. If you still can't find what you are looking for, try using the search box.

Absolute Antibody Partners with the Technical University of Denmark  to Offer Antibodies against Animal Venom Toxins

Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Technical University of Denmark to develop engineered recombinant antibodies specific for animal toxins, such as toxins from snake venoms.

Read the rest of entry »

Arctoris has announced the 2nd edition of BioTarget, a global business competition for drug discovery entrepreneurs.

Arctoris Ltd, an Oxford-based company that operates the world’s first fully automated drug discovery platform, has announced the 2nd edition of BioTarget, a global business competition for drug discovery entrepreneurs. BioTarget 2020 is now open for applications.

Read the rest of entry »

Domainex : LUNAC Therapeutics selects Domainex as its strategic drug discovery partner

Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapies.

Read the rest of entry »

Arecor Achieves Second License Milestone Payment From Global Pharmaceutical Partner

Arecor Ltd, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that it has achieved an important second, contractual milestone with one of its pharmaceutical partners. The first milestone was triggered in October 2017 following the signature of a license agreement between the parties.

Read the rest of entry »

Discovery Park potential recognised by Govt Life Sciences Opportunity Zone status

Discovery Park, the thriving science park for  ambitious and growing life sciences companies, has been named a Life Sciences Opportunity Zone (LSOZ) by the UK Government’s Office for Life Sciences.

Read the rest of entry »

Imperial College Spinout Addressing UK Transplant Organ Shortage

A spin-out from Imperial College, Accunea has developed vital organ transplant technology that will make available more organs for transplant and reduce the numbers of deaths due to increasing waiting list times.

Read the rest of entry »

Fieldfisher advised on £34 million worth of venture capital deals in life sciences in 2019

European law firm, Fieldfisher advised on £34 million (€40.3 million) worth of venture capital deals in the life sciences sector, last year.

Read the rest of entry »

AMSBIO: Easy Isolation of PBMCs from Whole Blood

The EZ PREP Peripheral Blood Mononuclear Cell Isolation Kit from AMSBIO is designed to efficiently isolate highly purified peripheral blood mononuclear cells (PBMCs) from fresh whole blood products by density gradient centrifugation.

Read the rest of entry »

Discovery Park: Sell-out ‘Two’s Company’ conference led by Pfizer UK, University of Kent, Kent, Surrey and Sussex AHSN

Sandwich, Kent, February 19 2020 – Do you want to immerse yourself in a blood vessel, build the perfect factory before you put a spade in the ground or send a version of yourself to deliver a speech in a foreign language on the other side of the world? Or how about testing a car 300 million times before it hits the road, planning surgery or talking to remote patients via a hologram?

Read the rest of entry »

Pathios Therapeutics announces appointment of Dr. Tobias Bopp as the foundational member of its Scientific Advisory Board

Oxford, UK – 11 February 2020 – Pathios Therapeutics Limited ("Pathios"), an innovative biotech company focused on the development of first-in-class therapies for cancer and autoimmune diseases, today announced that it has appointed Dr. Tobias Bopp, a leading academic and pioneer in the study of the influence of acidosis on tumour immunology, as the foundational member of its Scientific Advisory Board.

Read the rest of entry »

Pages: Previous12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.